Exclusive

Publication

Byline

Location

Clinical Trial: Comparison of Different Ventilation Modes for Reducing Kidney Motion During Retrograde Intrarenal Surgery

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07705646) titled 'Comparison of Different Ventilation Modes for Reducing Kidney Motion During Retrograde Intr... Read More


Clinical Trial: Below-Elbow Versus Initial Above-Elbow Casting for Distal Radius Fractures

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704879) titled 'Below-Elbow Versus Initial Above-Elbow Casting for Distal Radius Fractures' on July 11. Br... Read More


Clinical Trial: Serum Fetuin-A and COMP Levels in Knee Osteoarthritis

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07706569) titled 'Serum Fetuin-A and COMP Levels in Knee Osteoarthritis' on July 11. Brief Summary: The purp... Read More


Clinical Trial: Intraperitoneal Irrigation of Ondansteron in Combination With Lidocaine in Acute Postoperative Pain

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07706348) titled 'Intraperitoneal Irrigation of Ondansteron in Combination With Lidocaine in Acute Postoperat... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More


Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More